• Home
  • About Us
  • Technology
  • Pipeline
  • Partnerships
  • News & Publications
HDT Bio

Fierce Biotech: HDT Bio’s Zika and HIV vaccines generate immune responses in pregnant rabbits and their offspring

Mar 27, 2023 | In the News

Click here to view...

GeekWire: Seattle Startup HDT Bio Lands $1.8M U.S. Army Grant to Develop Nasal Spray Against Viruses

Aug 11, 2022 | In the News

Click here to view...

Public Library of Science: And Then There Were 33…The Latest 11 COVID Vaccines to Reach the Phase 3 Results Milestone

Aug 5, 2022 | In the News

Click here to view...

Pharmaceutical Technology: HDT Bio Receives Emergency Use Approval for Covid-19 Vaccine in India

Jun 30, 2022 | In the News

Click here to view...

GeekWire: COVID-19 Shots with Seattle Origins Reach Regulatory Milestones in South Korea, India

Jun 29, 2022 | In the News

Click here to view...

Spectrum News: The Quest is On for a “Universal” COVID-19 Vaccine, Is it Possible?

Mar 27, 2022 | In the News

Click here to view...
« Older Entries
Next Entries »

Recent Posts

  • FDA Greenlights HDT Bio’s First-in-Class HDT-321 for the Prevention of Deadly Tick-Borne Disease
  • Institutional Biosafety Committee
  • MalarVx licenses HDT Bio’s repRNA/LION™ Technology for Novel Malaria Vaccine
  • Science Direct: Some assembly required: a single-RNA vaccine against enterovirus-D68
  • Fierce Biotech: NIH establishes pandemic preparedness network, plans up to $100M in yearly funding for work on new treatments and vaccines

Recent Comments

No comments to show.

Privacy Policy

Terms of Use

©2024 HDT Bio

  • Follow
  • Follow